Evidence map›Paper›PMID 28858493›Full record

ArticleJournal of the American Chemical Society2017

Enantiospecific Solvolytic Functionalization of Bromochlorides.

Alexander J Burckle, Bálint Gál, Frederick J Seidl, Vasil H Vasilev, Noah Z Burns

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Catalytic Regio- and Enantioselective Haloazidation of Allylic Alcohols.Journal of the American Chemical Society · 2018
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander J BurckleDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.
Bálint GálDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.
Frederick J SeidlDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.
Vasil H VasilevDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.
Noah Z BurnsDepartment of Chemistry, Stanford University , Stanford, California 94305, United States.ORCID 0000-0003-1064-4507

Funding

Selective Halogenation Reactions for the Synthesis of Chiral Bioactive Small MoleculesR01GM114061 · NIGMS · STANFORD UNIVERSITY · PI BURNS, NOAH ZACHARY · 2015 to 2019
$1.5M
NIGMS NIH HHS R01 GM114061
6 · The paper itself

Abstract

Herein, we report that under mild solvolytic conditions, enantioenriched bromochlorides can be ionized, stereospecifically cyclized to an array of complex bromocyclic scaffolds, or intermolecularly trapped by exogenous nucleophiles. Mechanistic investigations support an ionic mechanism wherein the bromochloride serves as an enantioenriched bromonium surrogate. Several natural product-relevant motifs are accessed in enantioenriched form for the first time with high levels of stereocontrol, and this technology is applied to the scalable synthesis of a polycyclic brominated natural product. Arrays of nucleophiles including olefins, alkynes, heterocycles, and epoxides are competent traps in the bromonium-induced cyclizations, leading to the formation of enantioenriched mono-, bi-, and tricyclic products. This strategy is further amenable to intermolecular coupling between cinnamyl bromochlorides and a diverse set of commercially available nucleophiles. Collectively, this work demonstrates that enantioenriched bromonium chlorides are configurationally stable under solvolytic conditions in the presence of a variety of functional groups.

Indexed as

Acids, HeterocyclicAlkenesAlkynesBiological ProductsBromine CompoundsChloridesCyclizationEpoxy CompoundsIonsSolventsAcids, HeterocyclicAlkenesAlkynesBiological ProductsBromine CompoundsChloridesEpoxy CompoundsIonsSolvents

Identifiers

PMID28858493
PMCPMC5987033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.